Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next generation cancer and autoimmune therapeutics — antibody conjugates, bispecific antibodies and cytokine derivatives. Unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Antibody-Drug Congugates and IADCs
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):